Un Characterized LOC105374928: A Potential Drug Target and Biomarker
Un Characterized LOC105374928: A Potential Drug Target and Biomarker
Abstract:
LOC105374928 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It has been shown to play a critical role in various cellular processes, including cell adhesion, migration, and invasion. The identification of LOC105374928 as a potential drug target has significant implications for the development of new therapeutic approaches for various diseases.
Introduction:
LOC105374928 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It has been shown to play a critical role in various cellular processes, including cell adhesion, migration, and invasion. The identification of LOC105374928 as a potential drug target has significant implications for the development of new therapeutic approaches for various diseases.
Location and Expression:
LOC105374928 is a non-coding RNA molecule that is located in the nucleus of the human chromosome 6. It is expressed in various tissues and cells, including brain, heart, liver, and cancer cells. The expression of LOC105374928 has been shown to be regulated by various factors, including DNA methylation, histone modification, and post-transcriptional modification.
Function and Interaction:
LOC105374928 is involved in various cellular processes, including cell adhesion, migration, and invasion. It has been shown to play a critical role in the regulation of cell adhesion, as well as the migration and invasion of cancer cells. LOC105374928 has also been shown to interact with various proteins, including E-cadherin, N-cadherin, and vimentin. These interactions may play a critical role in the regulation of cellular processes and the development of various diseases.
Drug Target:
The identification of LOC105374928 as a potential drug target has significant implications for the development of new therapeutic approaches for various diseases. LOC105374928 has been shown to play a critical role in the regulation of cell adhesion, which is a crucial step in the development and progression of many diseases, including cancer. Therefore, the development of compounds that can modulate LOC105374928 activity may be an effective strategy for the development of new therapeutic approaches for cancer and other diseases.
Biomarker:
LOC105374928 has also been identified as a potential biomarker for various diseases. The regulation of LOC105374928 activity has been shown to be involved in the development and progression of various diseases, including cancer. Therefore, the measurement of LOC105374928 levels in various tissues and fluids, such as blood, urine, and tissue samples, may be a useful diagnostic tool for the diagnosis and prognosis of various diseases.
Conclusion:
LOC105374928 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its regulation of cellular processes, including cell adhesion, migration, and invasion, makes it an attractive target for the development of new therapeutic approaches for various diseases. The identification of LOC105374928 as a potential drug target and biomarker has significant implications for the development of new therapeutic approaches for cancer and other diseases. Further research is needed to fully understand the role of LOC105374928 in cellular processes and its potential as a drug target and biomarker.
Protein Name: Uncharacterized LOC105374928
The "LOC105374928 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105374928 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105374935 | LOC105374939 | LOC105374942 | LOC105374945 | LOC105374968 | LOC105374971 | LOC105374974 | LOC105374976 | LOC105374985 | LOC105374989 | LOC105375005 | LOC105375010 | LOC105375016 | LOC105375019 | LOC105375020 | LOC105375021 | LOC105375024 | LOC105375032 | LOC105375033 | LOC105375039 | LOC105375043 | LOC105375047 | LOC105375056 | LOC105375063 | LOC105375065 | LOC105375069 | LOC105375070 | LOC105375088 | LOC105375091 | LOC105375104 | LOC105375120 | LOC105375122 | LOC105375139 | LOC105375161 | LOC105375170 | LOC105375172 | LOC105375175 | LOC105375179 | LOC105375186 | LOC105375194 | LOC105375195 | LOC105375199 | LOC105375204 | LOC105375207 | LOC105375218 | LOC105375230 | LOC105375235 | LOC105375236 | LOC105375237 | LOC105375242 | LOC105375264 | LOC105375275 | LOC105375284 | LOC105375291 | LOC105375310 | LOC105375337 | LOC105375340 | LOC105375341 | LOC105375347 | LOC105375361 | LOC105375379 | LOC105375381 | LOC105375404 | LOC105375410 | LOC105375423 | LOC105375428 | LOC105375429 | LOC105375434 | LOC105375440 | LOC105375443 | LOC105375448 | LOC105375451 | LOC105375452 | LOC105375490 | LOC105375492 | LOC105375494 | LOC105375508 | LOC105375523 | LOC105375536 | LOC105375541 | LOC105375543 | LOC105375552 | LOC105375556 | LOC105375567 | LOC105375574 | LOC105375597 | LOC105375600 | LOC105375610 | LOC105375623 | LOC105375629 | LOC105375631 | LOC105375639 | LOC105375655 | LOC105375670 | LOC105375672 | LOC105375683 | LOC105375690 | LOC105375704 | LOC105375712 | LOC105375716
